How to Use the FDA Safety Communications Archive for Historical Research
Learn how to navigate the FDA Safety Communications Archive to research historical drug warnings, medical device recalls, and labeling changes since 2010.
Learn how to navigate the FDA Safety Communications Archive to research historical drug warnings, medical device recalls, and labeling changes since 2010.
Learn how to accurately verify drug recall notices and match affected medication lot numbers to ensure patient safety and regulatory compliance.
Generic drugs for children carry unique safety risks due to immature metabolism and formulation differences. This guide explains how to spot unsafe substitutions and use the KIDs List.
Learn how disrupted purine metabolism causes gout pain and discover evidence-based urate-lowering treatment options for lasting relief.
Learn which foods, supplements, and drugs interact with Warfarin. Understand INR monitoring, dietary restrictions, and safe management strategies for blood thinners.
During disasters or drug shortages, expired medications may be the only option left. Learn which ones are safer to use, which to avoid, and how to make smart decisions when no alternatives exist.
Triptans and SSRIs are often wrongly linked to serotonin syndrome. Evidence shows the risk is negligible - patients shouldn't avoid effective migraine treatment due to outdated warnings.
Generic drugs are just as effective as brand-name drugs but cost up to 85% less. The FDA requires them to have identical active ingredients and therapeutic effects. Learn how labeling, appearance, and cost differences don’t affect safety or performance.
Combination cold and allergy meds may seem convenient, but they're a leading cause of accidental overdose and dangerous drug interactions. Learn how to avoid acetaminophen overload, blood pressure spikes, and serotonin syndrome.
African-made antiretroviral generics are transforming HIV treatment access across the continent, reducing reliance on imports and building local health sovereignty. With WHO-prequalified TLD now in use and long-acting injectables on the horizon, Africa is leading its own HIV response.